A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and implementation of multi-national observational studies for post-marketing drug safety ...

The research supports Guallpa's claims. The Department of Transportation consistently says that protected bike infrastructure ...

By Dr. Liji Thomas, MD Analyzing nearly 11.5 million births across four decades, researchers use rigorous methods to show ...

In a Nutshell No measurable differences: Adults with prediabetes who ate 6-7 ounces of unprocessed beef daily for four weeks ...

JAMA named nine of the most influential studies of 2025, including three in neurology. Medscape interviews the researchers to explore the findings and what they could mean for brain health.

Despite greater muscle mass of transgender women 1-3 years after hormone therapyEvidence is of variable quality, but doesn't ...

By Dr. Priyom Bose, Ph.D. Large clinical trials and real-world data point to a familiar diabetes drug as a simple, safe way ...

Different CABG approaches have their own time and place, studies suggest ...

In A Nutshell Starting aspirin after age 70 did not prevent cancer in a study of nearly 20,000 older adults followed for ...

Ozempic, Mounjaro, and Zepbound can drive impressive weight loss, but stopping them is often followed by rapid weight regain.

Understand where real-world evidence most effectively complements or substitutes traditional trial data, from post-market surveillance and label expansion to challenging areas such as rare disease ...

Background Aortic stenosis (AS) frequently coexists with heart failure (HF), but its prevalence, prognostic impact and management across the full HF spectrum remain incompletely characterised. Methods ...